1. Home
  2. FARM vs HURA Comparison

FARM vs HURA Comparison

Compare FARM & HURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Farmer Brothers Company

FARM

Farmer Brothers Company

HOLD

Current Price

$1.54

Market Cap

33.3M

ML Signal

HOLD

Logo TuHURA Biosciences Inc.

HURA

TuHURA Biosciences Inc.

HOLD

Current Price

$1.70

Market Cap

35.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
FARM
HURA
Founded
1912
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Sector
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
33.3M
35.5M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
FARM
HURA
Price
$1.54
$1.70
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$2.75
$10.00
AVG Volume (30 Days)
77.5K
3.4M
Earning Date
05-25-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$342,281,000.00
N/A
Revenue This Year
$4.36
N/A
Revenue Next Year
$3.31
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.35
N/A
52 Week Low
$1.36
$0.41
52 Week High
$3.28
$4.41

Technical Indicators

Market Signals
Indicator
FARM
HURA
Relative Strength Index (RSI) 44.74 74.12
Support Level $1.43 $1.56
Resistance Level $1.61 $2.75
Average True Range (ATR) 0.08 0.28
MACD -0.01 0.07
Stochastic Oscillator 24.62 86.91

Price Performance

Historical Comparison
FARM
HURA

About FARM Farmer Brothers Company

Farmer Bros Co is engaged in manufacturing, wholesaling, and distributing coffee, tea, and culinary products to food-service establishments and retailers in the United States. The company's customers include restaurants, hotels, offices, casinos, convenience stores, healthcare facilities, and other food-service providers. The company's product categories include roast and ground coffee, frozen liquid coffee, flavored and unflavored iced and hot teas, culinary products, spices, and other beverages, such as cappuccino, cocoa, granitas, and ready-to-drink iced coffee.

About HURA TuHURA Biosciences Inc.

TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.

Share on Social Networks: